In addition, for the validation cohort, there was decreased risk of cancer‐related death with NRP1 expression in tumor cells (HR = 0.3, 95% CI = 0.2–0.5, p‐value <0.001) and perivascular NRP1 (HR = 0.3, 95% CI = 0.2–0.4, p‐value <0.001). The gene discussed is NRP1; the disease is cancer.